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ABSTRACT
The Sox2 gene is a key regulator of pluripotency embedded within an intron of a long noncoding RNA (ncRNA), termed Sox2
overlapping transcript (Sox2ot), which is transcribed in the same orientation. However, this ncRNA remains uncharacterized.
Here we show that Sox2ot has multiple transcription start sites associated with genomic features that indicate regulated
expression, including highly conserved elements (HCEs) and chromatin marks characteristic of gene promoters. To identify
biological processes in which Sox2ot may be involved, we analyzed its expression in several developmental systems, compared
to expression of Sox2. We show that Sox2ot is a stable transcript expressed in mouse embryonic stem cells, which, like Sox2, is
down-regulated upon induction of embryoid body (EB) differentiation. However, in contrast to Sox2, Sox2ot is up-regulated
during EB mesoderm-lineage differentiation. In adult mouse, Sox2ot isoforms were detected in tissues where Sox2 is expressed,
as well as in different tissues, supporting independent regulation of expression of the ncRNA. Sox2dot, an isoform of Sox2ot
transcribed from a distal HCE located >500 kb upstream of Sox2, was detected exclusively in the mouse brain, with enrichment
in regions of adult neurogenesis. In addition, Sox2ot isoforms are transcribed from HCEs upstream of Sox2 in other vertebrates,
including in several regions of the human brain. We also show that Sox2ot is dynamically regulated during chicken and
zebrafish embryogenesis, consistently associated with central nervous system structures. These observations provide insight into
the structure and regulation of the Sox2ot gene, and suggest conserved roles for Sox2ot orthologs during vertebrate
development.
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INTRODUCTION
Over the last decade, transcriptomic studies have revealed
that most of the genome of higher eukaryotes is transcribed
in developmentally regulated patterns, to produce a com-
plex set of overlapping and interlacing coding and non-
coding transcripts from both strands (Mattick and Makunin
2006; Willingham and Gingeras 2006). Over 30,000 puta-
tive full-length long (>200 nucleotides [nt]) non-protein-
coding RNAs (ncRNAs) have been catalogued in mouse
(Carninci et al. 2005), many of which are subjected to
splicing, but the biological roles of only a small number
have been investigated. Nevertheless, their specific expres-
sion patterns, conservation of promoters, splice site se-
quences and predicted structures, association with partic-
ular chromatin signatures, regulation by morphogens and
transcription factors, alternative splicing and altered ex-
pression in disease states, as well as evidence of evolu-
tionary selection, all suggest that many of these transcripts
are functional (Cawley et al. 2004; Carninci et al. 2005;
Washietl et al. 2005; Pang et al. 2006, 2007; Pollard et al.
2006; Ravasi et al. 2006; Torarinsson et al. 2006; Ponjavic
et al. 2007; Rinn et al. 2007; Dinger et al. 2008a; Mercer
et al. 2008; Guttman et al. 2009; Zhang et al. 2009). Indeed,
ncRNAs have been shown to regulate gene expression
through a large variety of mechanisms, including the control
of chromatin structure, transcription, mRNA processing,
and translation (Amaral et al. 2008) and are emerging as
important players in gene regulation during eukaryotic de-
velopment (Amaral and Mattick 2008).
Given the lack of currently known intrinsic features that
might provide insight into specific long ncRNA functions,
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a common strategy to study ncRNAs has been the analysis
of their expression and genomic relationship with adjacent
protein-coding loci. This approach has successfully revealed
cis-regulatory roles for several ncRNAs (Sleutels et al. 2002;
Feng et al. 2006; Martianov et al. 2007; Beltran et al. 2008;
Dinger et al. 2008a; Ebralidze et al. 2008; Pandey et al. 2008;
Wang et al. 2008; Yu et al. 2008). Recently, we identified
174 long, spliced ncRNAs that are dynamically regulated
during mouse embryonic stem (ES) cell differentiation,
many of which are associated and coordinately expressed
with genes that have important roles in the differentia-
tion process, including several homeobox-containing genes
(Dinger et al. 2008a). In fact, long ncRNA genes are com-
monly associated with transcription factor loci that control
development and are proposed to be a general component
in their regulation (Engstrom et al. 2006; Amaral and
Mattick 2008). Moreover, a number of ncRNAs exhibit
expression profiles similar to genes that have crucial roles
in ES pluripotency, such as Sox2, Nanog, and Pou5f1, indi-
cating that long ncRNAs may also participate in the regu-
latory networks that define the pluripotent state (Dinger
et al. 2008a).
Sox2 (SRY-box containing gene 2) is a key regulatory
factor involved in establishing and maintaining pluripo-
tency in vertebrate stem cells. It is a highly conserved
single-exon gene that encodes a high-mobility group tran-
scription factor expressed very early in development, in-
cluding in totipotent cells from the morula and inner cell
mass of blastocysts, and its ablation causes early embryonic
lethality in mice (Avilion et al. 2003; Masui et al. 2007).
Conditional knockouts of Sox2 have further demonstrated
important roles in conserved ontogenetic processes, espe-
cially in neural development (Mizuseki et al. 1998; Bylund
et al. 2003; Okuda et al. 2006). Sox2 is required for both
neural induction of the ectoderm and maintenance of
progenitor and neural stem cells during embryonic and
adult neurogenesis (Cai et al. 2002; Wegner and Stolt
2005; Cavallaro et al. 2008; Kim et al. 2008). Sox2 is also
expressed in glial precursors and proliferating astrocytes,
but it is down-regulated in neurons and in quiescent
astrocytes (Ferri et al. 2004; Komitova and Eriksson 2004;
Miyagi et al. 2004, 2006; Bani-Yaghoub et al. 2006). How-
ever, the mechanisms determining its differential regulation
in these neural cell lineages are unclear. In addition, Sox2 is
required for mouse retina and lens development (Kamachi
et al. 2001; Taranova et al. 2006), and heterozygous defi-
ciency in humans is associated with eye defects, such as
microphthalmia and anophtalmia, as well as other abnor-
malities, including forebrain and hippocampal malforma-
tion, and epilepsy (Fantes et al. 2003; Kelberman et al. 2006,
2008; Sisodiya et al. 2006).
Human SOX2 is required for ES self-renewal and pluri-
potency (Fong et al. 2008). It has recently generated great
therapeutic interest as a reprogramming factor (along with
Oct4/Klf4/c-Myc or Oct4/Nanog/Lin28) capable of inducing
pluripotency when ectopically expressed in a variety of
differentiated murine and human cells, the so-called induced
pluripotent stem (iPS) cells (Takahashi and Yamanaka 2006;
Okita et al. 2008; Park et al. 2008). Neural progenitor cells,
which express Sox2, can be reprogrammed into iPS cells when
transduced with only Oct4/Klf4, in which case endogenous
Sox2 is thought to facilitate reprogramming (Eminli et al.
2008). Therefore, elucidating the mechanisms that regulate
Sox2 expression is important to better understand and
manipulate its roles in the control of pluripotency.
Multiple mechanisms are implicated in the developmental
and tissue-specific regulation of Sox2, notably transcriptional
control via an array of highly conserved enhancers located
upstream and downstream from the gene, which have stage-
and tissue-specific activities (Zappone et al. 2000; Uchikawa
et al. 2003, 2004; Catena et al. 2004; Miyagi et al. 2004).
Recently, a study reporting the involvement ofmutations in
SOX2 in anophtalmia made the intriguing observation that
the SOX2 gene lies in an intron of a long multiexon ncRNA
that is transcribed in the same orientation (Fantes et al. 2003).
The described transcript in humans, named SOX2OT or
‘‘Sox2 overlapping transcript’’ (approved by the HUGO Gene
Nomenclature Committee; also ‘‘non-protein-coding RNA
43,’’ HGNC ID:20209), is 3.4 kb long, and shares 88% iden-
tity with orthologous sequences in mouse (Fantes et al.
2003). SOX2OT has been postulated to participate in SOX2
regulation (Fantes et al. 2003), but its expression patterns
and potential functions have not been studied.
Our group previously observed that at least one isoform
of Sox2ot is expressed in the mouse brain in regions of adult
neurogenesis (Mercer et al. 2008), indicating that this
ncRNA may have roles in processes related to the Sox2
gene. In this work, to obtain insights into its function and
regulation, we examined the expression of Sox2ot tran-
scripts in different developmental systems and its relation-
ship to Sox2 expression. We found that Sox2ot is dynam-
ically expressed in different developmental processes in
which Sox2 plays important roles, including mouse ES cell
and neural cell differentiation, but it is also present in
tissues where Sox2 is not detected. Sox2ot orthologs are
expressed in different vertebrates, and are regulated during
development of mouse, chicken, and zebrafish embryos,
with a conserved association with the central nervous sys-
tem. The expression profiles of Sox2ot, as well as its evo-
lutionarily preserved genomic association with Sox2, suggest
that it has conserved functions in vertebrate development,
and that it may participate in the regulation of Sox2 or
related processes.
RESULTS
Sox2ot transcripts and locus structure
SOX2OT was originally reported as a spliced ncRNA
mapping to human chromosome 3q26.3-q27, with an
Amaral et al.
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intron overlapping the SOX2 gene in the same transcrip-
tional orientation (Fantes et al. 2003). We analyzed the
orthologous region in mouse and observed expressed se-
quence tags (ESTs) derived from several alternative iso-
forms of Sox2ot, with multiple alternative promoters,
splicing and polyadenylation sites (Fig. 1; Supplemental
Fig. 1). AceView annotation (Thierry-Mieg and Thierry-
Mieg 2006) supports 16 different canonical GT-AG introns
in at least 13 splicing variants and six alternative transcrip-
tion start sites (TSSs). Four Sox2ot full-length sequences
cloned from mouse tissues (Strausberg et al. 2002; Numata
et al. 2003; Carninci et al. 2005) range in size from 638 nt
(GenBank accession no. BY721402) to z3.5 kb (accession
no. AK031919).
Analysis of protein-coding potential of mouse and
human Sox2ot/SOX2OT full-length cloned sequences with
the software CRITICA, which uses a combination of sta-
tistical and comparative parameters, such as open reading
frame (ORF) length, synonymous versus nonsynonymous
base substitution rates, and similarity to known proteins
(Badger and Olsen 1999; Frith et al. 2006), indicates no
significant coding potential, although it remains possible
that small proteins or peptides are encoded within the
transcript (Dinger et al. 2008b).
The existence of poly(A) and 59 cap structures, inferred
from full-length cloning strategies, suggests that Sox2ot is
transcribed by RNA polymerase II (RNAP II), and there-
fore represents a putative ‘‘mRNA-like’’ ncRNA (Numata
et al. 2003). Mapping of TSSs of Sox2ot determined from
EST clones that include the 59end of transcripts (Carninci
et al. 2005; Kimura et al. 2006) showed several novel iso-
forms with alternative TSSs (Fig. 1A; Supplemental Fig. 1).
FIGURE 1. Genomic organization of Sox2ot locus in mouse. (A) Genome Browser (Hinrichs et al. 2006) view of Sox2 overlapping transcripts
showing ‘‘Full-length clones’’ (mouse mRNAs from GenBank) and distal ‘‘spliced ESTs’’ tracks (accession numbers on the left). *The depicted
ESTs represent some of Sox2ot splicing isoforms (for complete list of spliced ESTs see Supplemental Table 1), including ‘‘Sox2 distal overlapping
transcript’’ (Sox2dot). Mouse highly conserved elements (HCEs 1–7) associated with Sox2ot start sites and exons in mouse or human (guide
gray boxes, see Supplemental Fig. 1) are depicted by a Condor identifier (http://condor.fugu.biology.qmul.ac.uk/) (Woolfe et al. 2007). Also
indicated are the Multiz 17-way vertebrate conservation (phastCons score histogram), TFRs, H3K4me3 (green), and H3K27me3 (red) chromatin
marks from mouse brain obtained from UCSC Genome Browser tracks. (B) Detailed view of Sox2ot region proximal to Sox2, indicating positions
of primer pairs used in RT-PCR analysis of Sox2 (blue arrows) and Sox2ot expression (opposite arrows below and above transcript representing
‘‘Sox2ot a’’ and ‘‘Sox2ot b’’ primer pairs, respectively); splicing isoforms identified by available RNA-Seq data in mouse brain (blue),
undifferentiated ES cells (green), and differentiating EBs (orange). The positions of an RNAz predicted secondary structure (P > 0.9)
(Supplemental Fig. 3) and the Allen brain probe (ABA probe) used to determine Sox2ot expression (Mercer et al. 2008) in mouse brain sections
are shown.
Sox2ot transcripts in vertebrate development
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We also analyzed published chromatin modification maps of
active (tri-methylated histone 3 lysine 4, H3K4me3) or
repressed (trimethylated histone 3 lysine 27, H3K4me27)
promoters obtained by chromatin immunoprecipitation-
sequencing (ChIP-Seq) (Mikkelsen et al. 2007), and found
support for multiple TSSs of Sox2ot (Fig. 1A). These pro-
moter regions are associated with noncoding sequence blocks
of high conservation in vertebrates (Woolfe et al. 2004,
2007), here termed highly conserved elements (HCEs) 1–7
encompassed in the Sox2ot locus. These blocks also largely
correspond to ‘‘transposon free regions’’ (TFRs) (sequences
over 5 kb long, which have remained resistant to trans-
poson fixation throughout vertebrate evolution and appear
to comprise extended regulatory sequences controlling the
expression of genes that are central to early development)
(Fig. 1A; Supplemental Fig. 1; Simons et al. 2006). The
novel transcripts include a distal isoform associated with
HCE 1, whose TSS is located more than 0.5 Mb upstream
of Sox2 in mouse, and is hereafter referred to as Sox2dot
(‘‘Sox2 distal overlapping transcript’’). HCE 1 has been
shown to have enhancer activity specific to the forebrain of
developing mouse embryos (Supplemental Fig. 2; Pennacchio
et al. 2006).
In addition, we identified a putative promoter between
HCEs 2 and 3 that is marked by H3K4me3 and H3K27me3
modifications, as well as a TFR, but which is not associated
with any mapped alternative TSS of Sox2ot or any EST
sequence (Fig. 1A). However, we found a novel ncRNA
associated with this element from a published collection of
recently identified long intergenic ncRNAs (lincRNAs)
(Guttman et al. 2009; data not shown). This, and additional
ESTs located in the introns of Sox2ot, further highlight the
transcriptional complexity associated with the Sox2ot locus.
Expression of Sox2ot in mouse tissues and ES cell
differentiation
Inspection of the distribution of spliced ESTs in mouse
tissues indicated a predominance of Sox2ot transcription in
the central nervous system (CNS) (Supplemental Table 1).
Moreover, analysis of RNA deep sequencing (RNA-Seq)
data (Cloonan et al. 2008; Mortazavi et al. 2008) showed
the presence of alternative splicing isoforms of Sox2ot in
mouse brain, as well as in pluripotent and differentiating
embryonic stem cells (Fig. 1B).
Because of the importance of Sox2 in these systems, we
first examined the regulation of Sox2ot, along with Sox2, in
undifferentiated mouse ES cells and during differentiation
as embryoid bodies (EBs) over a 16-d time course (see
Materials and Methods) using quantitative real-time PCR
(qRT-PCR). Similarly to Sox2, Sox2ot is expressed in
pluripotent ES cells and is initially down-regulated upon
EB differentiation (Fig. 2A). However, unlike Sox2, the
ncRNA is reactivated after 6 d of differentiation (Fig. 2A),
which coincides with induction of mesoderm differentia-
tion programs (Bruce et al. 2007; Dinger et al. 2008a). We
did not detect expression of the Sox2dot isoform in these
samples at any time point (data not shown).
In addition, to confirm the transcription of Sox2ot by
RNAPII and to assess transcript stability, we treated mouse
ES cells with RNAPII inhibitor a-amanitin for 12, 24, and
48 h, and quantified the levels of Sox2 and Sox2ot in treated
and nontreated cells during EB differentiation. While Sox2
mRNA levels are dramatically reduced after 12 h of
treatment, Sox2ot levels were not significantly affected in
the same period and significant reduction was observed
only after 24 h of treatment (Fig. 2B). Similar results were
observed using nondifferentiating ES cells treated with
a-amanitin (data not shown), indicating that Sox2ot is
more stable than Sox2 mRNA in ES cells.
By examination of Sox2ot expression in mouse embryos
(E10–E12 days post-fertilization [dpf]) and in adult brain
using Northern blot, we detected a major band of z3 kb
(Fig. 2C). The expression was stronger in the brain, where
multiple additional bands of z1, 4, 6, and >10 kb,
presumably consisting of alternative isoforms, can be
detected. To further evaluate the regulation of the expres-
sion of Sox2ot RNAs and the relationship with Sox2 in
mouse, we analyzed their expression in mouse embryo,
adult tissues, and cell lines by RT-PCR. By using a primer
pair that detected Sox2ot last exon (‘‘Sox2ot a’’) (Fig. 1B),
the ncRNA was detected in mouse embryo (E10–E12 dpf)
and in different adult mouse tissues, both in tissues where
Sox2 was also present, such as brain, lung, and heart (Fig.
2D, right panels), and in tissues where the mRNA was not
detected, such as testis (Fig. 2D, left panels). Using primers
spanning an exon–exon junction (‘‘Sox2ot b’’) (Fig. 1B),
a cassette exon was detected, which is differentially regu-
lated in mouse tissues (Fig. 2D, cf. lower band of ‘‘Sox2ot
b’’ in brain and ES cells). The bands corresponding to the
different isoforms were sequenced to confirm their identity,
and the regulated expression of isoforms was also evidenced
by detection of different splicing junctions in the RNA-Seq
data from different sources (Fig. 1B).
Sox2dot isoform was present in whole embryo and new-
born mouse, but was detected only in the brain among the
adult tissues tested (Fig. 2D). The expression of Sox2dot and
isoforms of Sox2ot with alternative TSSs in the mouse brain
is supported by the presence of H3K4me3 histone modifi-
cations associated with their promoter regions (Fig. 1A). In
addition, the observation that H3K27me3 modifications can
also be associated with alternative TSSs indicates that ini-
tiation of Sox2ot transcription from different promoters can
be regulated at the chromatin level (Fig. 1A).
Sox2ot and Sox2dot are dynamically regulated during
mouse neurogenesis
Sox2ot expression was previously observed in the mouse
brain in zones of adult neurogenesis (Mercer et al. 2008).
Amaral et al.
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This pattern was detected by in situ hybridization (ISH)
with a probe targeting a long (z2.8 kb) last exon (Fig. 1B,
GenBank accession no. AK031919). In addition, Sox2ot
ESTs are found in mouse differentiating neural stem cells
libraries (Supplemental Table 1), and its expression can be
detected in a variety of mouse primary neuronal cell
cultures (data not shown).
To further explore the possible involvement of Sox2ot in
neural differentiation processes, we next examined the
expression of the RNAs using the ‘‘neurosphere assay,’’
an in vitro system of neurogenesis with cultures of neuro-
spheres originated from neural stem cells and undifferen-
tiated precursors present in the adult mouse subventricular
zone (Reynolds and Rietze 2005, 2006). Neurospheres were
cultured for up to 7 d in differentiation media, which
progressively enriches for neurons and glial cells (Rietze
and Reynolds 2006). Analysis of Beta-III tubulin (Tubb3)
and Glial fibrillary acidic protein (Gfap) mRNA expression
by qRT-PCR indicates an increasing enrichment for neu-
rons and astrocytes, respectively, after 2 and 7 d of culture
(Fig. 3A). Sox2 and Sox2ot were present in the cultured
neurospheres (passage 2) (Fig. 3A), observed at similar
levels after eight passages (data not shown). In addition,
both transcripts were concordantly up-regulated in neuro-
spheres after 2 d of culture in differentiation medium, and
slightly down-regulated after 7 d, a pattern similar to that
observed for Nestin (Fig. 3A). Sox2ot absolute expression
levels were significantly higher in these neural cell types
than in ES cells (data not shown).
Sox2dot was expressed at low levels in neurospheres, but
showed a marked increase after 7 d of culture, indicating
specific expression in the more differentiated population of
neurons and glial cells (Fig. 3B). We then performed ISH to
examine the expression of Sox2dot in adult mouse brain
sections. Like Sox2ot, Sox2dot was also detected in zones of
adult neurogenesis (Zhao et al. 2008) in the subventricular
zone, rostral migratory stream and olfactory bulb, with
a higher intensity in the latter (Fig. 3C), which contains
a higher number of differentiated neurons, consistent with
the expression observed in the neurospheres enriched in
differentiated cells.
Although the in vitro neurosphere differentiation system
originates a heterogeneous population of cells, including
progenitors and differentiating neuronal and glial cells
FIGURE 2. Expression profile of Sox2 and Sox2ot in mouse ES cells and tissues. (A) qRT-PCR analysis of Sox2 and Sox2ot levels in EB over a 16-d
differentiation time course (expressed relative to day 0), and (B) in differentiating EBs treated (solid lines) or nontreated (dashed lines) with
a-amanitin (expressed relative to 0 h of treatment). Error bars show standard deviation (SD) for at least three replicates. (C) Northern blot
detection of Sox2ot expression in mouse embryos and adult brain. (D) RT-PCR performed with different primer pairs (see Materials and Methods
for primer sequences) detecting different regions and isoforms of Sox2ot (‘‘Sox2ot a,’’ ‘‘Sox2ot b,’’ and Sox2dot). *Embryo: RNA pool from E10–E12
dpf embryos. RT-: No reverse transcriptase control with embryonic RNA.
Sox2ot transcripts in vertebrate development
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(Jensen and Parmar 2006), these results suggest that
Sox2ot isoforms are present in neural cells and are dy-
namically regulated during differentiation. Interestingly,
highly enriched binding of neuronal transcriptional re-
pressor NRSF/REST has been previously validated in con-
served sites upstream of Sox2ot (Mortazavi et al. 2006).
NRSF/REST has been proposed to target several long
ncRNAs in mouse and human neural cell differentiation
models, and may represent a general mechanism of
regulation of ncRNA expression in neuronal development
(Johnson et al. 2009).
Sox2ot is transcribed from highly conserved elements
in vertebrates
We observed that multiple SOX2OT TSSs in humans,
determined by 59-end sequencing of ‘‘oligo-cap’’ cDNA
libraries (Kimura et al. 2006), are associated with ortho-
logous HCEs (Supplemental Fig. 1; Supplemental Table 1).
Analysis of ultraconserved elements
(UCEs), blocks with at least 100 base
pairs (bp) that have 100% conservation
in placental mammals (Stephen et al.
2008), showed that the z850 kb locus
spanned by SOX2OT/DOT transcripts
in humans contains 46 UCEs that oc-
cupy 1.09% of this region (average
block size of 204 bp) (Supplemental
Fig. 1A). This represents 15.6-fold en-
richment relative to the entire genome
(UCE coverage of 0.07%, average block
size of 155 bp), underlying a high den-
sity of functional elements spanned by
SOX2OT transcription. The longest UCE
in the region in humans (646 bp long)
corresponds to HCE 1, which in mouse
comprises a sequence of 554 bp that
presents 95% identity with human and
83% with zebrafish genomic sequences.
As observed in mouse, these HCEs
associated with SOX2OT TSSs closely
correspond to TFRs in humans; which
further suggests that these sequences
have been subjected to functional con-
straints across mammals (Supplemental
Fig. 1). Moreover, HCEs upstream of
Sox2 are also identified in chicken
(Uchikawa et al. 2004) and zebrafish
genomes (Supplemental Fig. 1), and as-
sociated Sox2ot ESTs are not only found
in these species, but also in other
vertebrates with low EST coverage, such
as Xenopus, cow, macaque, and orang-
utan (data not shown). Not all HCEs
associated with Sox2ot TSSs in human
and mouse are associated with TSSs in zebrafish (Supple-
mental Fig. 1), but this may be due to the small EST
coverage and lack of 59 end-cloned EST information in the
latter.
At the primary sequence level, although Fantes et al.
(2003) reported an identity of 88% of human SOX2OT
transcribed from HCE 4 and 5 with mouse ESTs, the
sequence similarity is restricted to specific regions of the
transcript, and, because different exons have different
conservation levels, the overall sequence conservation
varies among alternative isoforms (Supplemental Fig. 1A).
For example, the sequence of 2,971 bases [excluding the
poly(A) tail] from Sox2ot isoform transcribed from HCE 4
in mouse (GenBank accession no. BC057611) is highly
conserved in the rat genome, presenting z90% identity in
a continuous stretch of 2967 bases and all GT-AG splice
sites conserved. However, the same sequence restricts to
384 nt with 91.2% identity in the human genome (con-
centrating in the exons immediately flanking Sox2, whose
FIGURE 3. Sox2ot dynamic expression in mouse adult neurogenesis. Detection of (A) Sox2
and Sox2ot, and (B) Sox2dot, in mouse differentiating neurospheres by qRT-PCR (expressed
relative to Hprt levels). Levels of neural markers Nestin, Beta-III tubulin (Tubb3), and Glial
fibrillary acidic protein (Gfap) were also measured, and error bars showing SD were
determined from at least three replicates. (C) In situ hybridization of sagittal adult mouse
brain section showed expression of Sox2dot in zones of adult neurogenesis. Detailed anterior
view indicating the olfactory bulb (OB), rostral migratory stream (RMS), and subventricular
zone (SVZ).
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splice sites are also conserved). These stretches can overlap
highly conserved elements, such as HCE 7 that falls inside
the last exons of mouse and human Sox2ot/SOX2OT
(Supplemental Fig. 4). This element is part of an evolu-
tionarily constrained region that encompasses a sequence of
106 nt predicted to form a conserved secondary structure
(RNAz, P > 0.9) (Fig. 1B; Supplemental Fig. 3), which may
represent a conserved functional element within Sox2ot.
Finally, some exons of SOX2OT may be species- or clade-
specific, as evidenced by the exon between HCEs 1 and 2,
which is present in all SOX2DOT ESTs in humans and has
splice site conserved only in primates, but is not detected in
mouse (not present in ESTs nor detected by RT-PCR)
(Supplemental Fig. 1A,B, data not shown).
Developmental regulation of Sox2ot in vertebrates
In light of the association of Sox2ot with highly conserved
sequences and the identification of ESTs in different ver-
tebrates, we evaluated whether Sox2ot transcripts are
present and regulated during vertebrate embryonic devel-
opment by examining the expression of Sox2 and Sox2ot/
dot orthologs in chicken and zebrafish embryos (Fig. 4).
Using qRT-PCR, Sox2ot was detected during chicken de-
velopment, with increasing levels observed after 2 d of
embryonic development, similar to the pattern observed for
Sox2 (Fig. 4A), although with lower absolute expression
levels. Expression of both Sox2 and Sox2ot was enriched to
the head of 6.5-d chicken embryos, compared to the limbs
and whole body (Fig. 4A).
In zebrafish embryos, Northern blot analysis of sox2ot
expression at 10, 30, and 78 h post-fertilization (hpf) stages
showed a major band of z2.5 kb at 30 hpf, as well as less
intense bands of z1.5 and z6 kb, which are also present in
the other stages (Supplemental Fig. 4A), indicating de-
velopmental regulation of alternative isoforms. Moreover,
PCR using cDNA from zebrafish embryos and primers
positioned in the first and last exons of sox2ot EST
(accession no. EB947627), followed by sequencing, dem-
onstrated the presence of different splicing isoforms (Sup-
plemental Fig. 1C), including an isoform that skips the
exon associated with HCE 5 and an isoform that contains
a novel exon of 207 bases positioned between HCE 4 and 5
(deposited as GenBank accession nos. GO599877, GO599878,
and GO599879).
In qRT-PCR analysis of a zebrafish developmental series
from two-cell stage embryos to 5 dpf, sox2 and sox2ot
presented concordant up-regulation after sphere stage (Fig.
4B). This corresponds to the activation of zygotic tran-
scription at midblastula transition, suggesting that sox2 and
sox2ot are both early zygotic genes in zebrafish. However,
there is an apparent divergence in their expression patterns
after tailbud stage when sox2ot total levels are reduced,
although later in development at 5 dpf, both sox2 and
sox2ot are highly expressed (Fig. 4B). Interestingly, after
zygotic activation, sox2dot is expressed at very low levels,
but is dramatically induced at 5 dpf (Fig. 4D). By this
developmental stage, the zebrafish has completed most as-
pects of organogenesis and already contains well-developed
neuroanatomical features (Kimmel et al. 1995), a result that
may parallel the expression of Sox2dot in mouse brain and
in differentiated neurosphere cells.
To explore the temporospatial expression pattern of the
transcripts in zebrafish embryos, we used whole-mount
ISH with riboprobes for sox2 and sox2ot at tailbud and 28
hpf stages. We detected presumptive neurectodermal ex-
pression of sox2 at tailbud stage, as previously described
(Okuda et al. 2006). At the same stage, sox2ot was also
expressed in neurectodermal tissue, but with a more dif-
fused pattern (Fig. 4C). Later at 28 hpf, both transcripts
were highly expressed throughout the developing brain and
eyes, and also at lower levels posteriorly in the neural tube
(Fig. 4C). Specific expression of sox2ot in the retina and
CNS was also observed by section ISH using 48 hpf em-
bryos (Supplemental Fig. 4), and this was maintained in the
brain throughout embryonic development until at least
6 dpf (data not shown). However, sox2ot expression at 28
hpf was broader, observed at high levels in the pharyngeal
arches, but lower in some regions of sox2 expression, such
as the otic placodes. Moreover, at this stage, unlike sox2,
sox2ot was also detected at posterior mesoderm, with dis-
tinct expression in the gut, lateral mesoderm, and posterior
blood island (Fig. 4C), a pattern that was supported by
section ISH with 48 hpf embryos (Supplemental Fig. 4).
These results point to a complex expression pattern for
sox2ot, which overlaps with sox2 particularly in the CNS,
but presents a broader distribution, especially in mesoderm
tissues during development.
Finally, to gain insight into the expression of SOX2OT in
humans, we used EST and published expression data
information to examine transcript distribution. Available
microarray expression data for several normal human
tissues show the highest expression of SOX2OT in the
brain and spinal cord (GEO Data Set Records GDS423 and
GDS1085) (Shyamsundar et al. 2005; Yanai et al. 2005).
qRT-PCR analysis of several human tissues confirmed that
the levels of SOX2OT are orders of magnitude higher in the
brain, where SOX2 is also predominantly expressed, but is
also detected in other tissues such as testis (Fig. 4E). In
addition, we analyzed the presence of 202 spliced ESTs
originating from the SOX2OT-associated HCEs in different
EST libraries (Supplemental Table 1). The majority of
SOX2OT spliced ESTs in humans (85% or 172/202 ESTs)
originate from HCE 5, which is also the HCE with the
highest number of associated Sox2ot ESTs in mouse
(Supplemental Table 1). Consistent with the microarray
and qRT-PCR data, the relative EST frequency of SOX2OT
in human tissues (see Materials and Methods) indicates
a predominance in CNS libraries, including fetal brain and
eyes, with only 16 out of 202 spliced ESTs not assigned to
Sox2ot transcripts in vertebrate development
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FIGURE 4. Expression of Sox2ot orthologs in different vertebrate species. (A) Relative expression of Sox2 and Sox2ot in chicken embryos as
determined by qRT-PCR (relative to 2.5-d embryos). (B–D) Expression of sox2 and sox2ot/dot in zebrafish embryos determined by qRT-PCR
(B,D) (expressed relative to eF1a levels), and whole mount in situ hybridization with zebrafish embryos at tailbud stage and 28 h post-fertilization
(hpf ) embryos (C; anterior to the top with lateral view of embryos in upper and middle panels, and dorsal view in lower panel). alpm: Anterior
lateral plate mesoderm, ba: branchial arches, Fb: forebrain, Hb: hindbrain, Mb: midbrain, Ne: neurectoderm, nt: neural tube, olp: olfactory
placode, otp: otic placode, picm: posterior intermediate cell mass, and Re: retina. (E) Expression of SOX2OT and SOX2 in human tissues
determined by qRT-PCR (relative to 18S rRNA levels). (F) Normalized EST distribution of SOX2OT ESTs in human tissue libraries (%), where
(x:n) indicates the number of SOX2OT spliced ESTs (x) over the total number of ESTs (n) in each tissue (see Materials and Methods). n/a: Not
available. Primer sequences are provided in Supplemental Table 2.
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brain or eye tissues (of which two were obtained from testis
and 10 from kidney tumor) (Fig. 4F), with similar results in
mouse (Supplemental Table 1). The tissue with greatest
enrichment in human SOX2OT ESTs is ‘‘lens,’’ with a pro-
portion of 17.5% of SOX2OT expression relative to all
libraries (although this library has a smaller coverage, with
z1300 ESTs), followed by subthalamic nucleus (13.5%)
and Alzheimer cortex (13%), as well as an enrichment in
kidney tumor libraries (7.4%), while it is found in lowest
relative abundance in cerebellum (0.3%). It is important to
notice that we only considered spliced ESTs, for which
there is information about the transcript orientation and
connectivity to SOX2OT. Nonetheless, this distribution
shows that SOX2OT is highly enriched in the human brain
and suggests that its expression is spatially regulated.
DISCUSSION
Most RNAs transcribed from eukaryotic genomes have
little or no protein-coding potential, and the vast majority
is currently defined as ‘‘transcripts of unknown function’’
(TUF) (Willingham and Gingeras 2006). A first necessary
step toward their characterization is to determine the tis-
sues and physiological processes in which such RNAs are
expressed and may play specific roles. Several studies have
shown specific expression of large numbers of ncRNAs
(Ravasi et al. 2006; Louro et al. 2007; Nakaya et al. 2007;
Dinger et al. 2008a; Mercer et al. 2008; Sunwoo et al. 2008).
Moreover, long ncRNAs are dynamically regulated during
animal development, supporting the idea that they are
involved in differentiation and developmental processes
(Amaral and Mattick 2008).
An emerging common feature of the set of conserved
genes for regulatory proteins that direct multicellular de-
velopment is their genomic association with long ncRNAs,
with accumulating examples of ncRNAs that regulate their
associated genes at different levels (Amaral and Mattick
2008). This set includes the transcription factor SOX2,
embedded within the intron of a putative long ncRNA,
SOX2OT, which was proposed to play a role in the tran-
scriptional regulation of SOX2 expression (Fantes et al.
2003). In mouse, Sox2 regulates a large number of genes
(Boyer et al. 2005; Chen et al. 2008), and precise regulation
of its dosage is critical for the temporal and spatial regula-
tion of differentiation processes, with small changes dra-
matically altering the self-renewal and pluripotency capacity
of ES cells (Taranova et al. 2006; Kopp et al. 2008). Indeed,
Sox2 is thought to function as a molecular ‘‘rheostat’’ con-
trolling key transcriptional regulatory networks in stem
cells (Boer et al. 2007; Kopp et al. 2008). However, the
mechanisms regulating Sox2 expression are still being
elucidated, and include regulation at the chromatin struc-
ture level (Sikorska et al. 2008), multiple transcription fac-
tors (Boyer et al. 2005), and post-transcriptional regulation
by microRNAs (Tay et al. 2008).
In this work, we examined the expression patterns of
Sox2ot and Sox2 in developmental systems, especially those
where Sox2 has well-characterized roles. We found that
Sox2ot is a stable RNA transcribed in mouse ES cells, and
its expression profile was similar to Sox2 in mouse early
differentiating EBs and neurospheres, as well as in some
adult tissues. However, Sox2ot was also differentially regu-
lated and present in tissues where Sox2 was not detected,
indicating that expression of Sox2ot does not simply reflect
the transcriptional status of Sox2. Indeed, sox2ot expression
in zebrafish embryos was broader than for sox2, including
in mesodermal tissues, a result that may parallel the up-
regulation of Sox2ot in mouse ES differentiation into meso-
derm lineages.
These expression patterns indicate that Sox2 and Sox2ot
may have complex functional relationships. Because Sox2ot
expression overlapped with Sox2 expression in all of the
different systems examined, Sox2ot could be involved in
the activation of Sox2 in some tissues. If this is the case, the
fact that Sox2ot is also present in tissues where Sox2 is not
detected indicates that it is not sufficient for the activation,
but must act in conjunction with the different regulatory
factors that control the expression of Sox2 (see above).
Nevertheless, although the conserved association between
Sox2ot and Sox2 in vertebrates supports a functional re-
lationship, Sox2ot may have additional roles that are
unrelated or tangential to the regulation of Sox2. The evolu-
tionarily preserved association and the overlap in the ex-
pression patterns could be a consequence of the sharing of
regulatory elements that control the expression of both
Sox2ot and Sox2. Finally, regulation of Sox2ot by Sox2 is
also possible, but we did not find evidence of Sox2 binding
in Sox2ot proximal promoter regions in published ChIP-
Seq data for Sox2 in mouse ES cells (Chen et al. 2008; data
not shown).
Supporting a role for Sox2ot in vertebrate development,
we observed that the expression of the ortholog transcripts
is differentially regulated in human tissues and dynamically
modulated in zebrafish and chicken embryos. The observed
expression was consistently associated with CNS tissues,
which is a pattern observed for a large number of ncRNAs
that may play roles in animal brain development and
function (Amaral and Mattick 2008). Nevertheless, while
the inferred promoter regions of Sox2ot are highly con-
served, the primary sequence of the transcript has conser-
vation in limited regions and contains repeat elements,
features that are also present in other characterized ncRNAs
(Amaral and Mattick 2008). In addition, these observations
are consistent with previous findings that ncRNA sequences
have more plasticity to evolve (Pang et al. 2006), but have
also, on average, higher promoter conservation compared
to protein-coding genes (Carninci et al. 2005; Ponjavic
et al. 2007).
We observed that several Sox2ot isoforms originating
from alternative TSSs are also associated with chromatin
Sox2ot transcripts in vertebrate development
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modifications characteristic of bona fide promoters and
with HCEs (Fig. 1; Supplemental Fig. 1). Indeed, it is
known that when HCEs (which often have enhancer
activity) are localized in introns, they are generally associ-
ated with alternative downstream TSSs from the host gene
(Vavouri et al. 2007). Moreover, the upstream TSSs ob-
served for Sox2ot isoforms are common in the organization
of the metazoan transcriptome, in which many transcripts
have distal 59 exons, sometimes located several hundreds
of kilobases upstream, and are expressed from alternate
promoters that are tissue- or cell-line-specific (Kimura
et al. 2006; Manak et al. 2006; Denoeud et al. 2007). We
found evidence that Sox2ot alternative promoters can be
differentially regulated, as indicated by Sox2dot, a novel
isoform of Sox2ot that has a unique tissue expression
pattern (detection in adult mouse restricted to brain) and
different profiles in the ES and neurosphere differen-
tiation assays. The differential regulation of Sox2ot iso-
forms, including the extensive occurrence of alternative
splicing, may indicate specific roles for these different
transcripts.
Similar to Sox2ot, the long spliced ncRNAs Evf-1 and
Evf-2 are transcribed from alternative TSSs that correspond
to ultraconserved enhancers associated with the Dlx5/6
genes, which have important roles in development (Kohtz
and Fishell 2004; Feng et al. 2006). Interestingly, in mouse
neural cells, the Evf-2 isoform was shown to mediate the
transcriptional activity of the associated ultraconserved
element by interacting and recruiting the Dlx2 transcrip-
tional activator to the enhancer (Feng et al. 2006). Most
recently, the function of Evf-2 was analyzed in mouse
embryos by insertion of premature termination sites that
truncate Evf-2, which caused a specific neural phenotype
and demonstrated regulation of the enhancer by the
ncRNA in vivo (Bond et al. 2009). A similar mechanism
has been suggested for ncRNAs transcribed from highly
conserved elements associated with other Dlx genes (Dinger
et al. 2008a). Given the high density of conserved elements
in the locus and the association of Sox2ot transcripts with
different HCEs, including Sox2dot with the HCE 1 neural
enhancer, one possibility is that Sox2ot transcripts or
transcription are also involved in regulation of enhancer
activity.
Sikorska et al. (2008) showed that epigenetic modifica-
tions of the SOX2 enhancers SRR1 and SRR2A correlate
with high level of SOX2 expression during cell differenti-
ation (Sikorska et al. 2008), and here we observed that
Sox2ot-associated HCEs are marked by chromatin activa-
tion and/or repression marks (Fig. 1A). In addition, the
region surrounding Sox2 flanked by Sox2ot exons corre-
sponds to a very large TFR (>30 kb in mouse and human),
and comprises a broad region (>20 kb) marked by histone
modifications characteristic of transcriptionally active pro-
moters (H3K4me3) in the mouse brain (Fig. 1A; Supple-
mental Fig. 1). This unusual chromatin structure has been
reported in mouse ES cells, in which transcriptional
elongation marks (H3K36me3) also extend far downstream
(>15 kb) from the Sox2 annotated 39 end (Mikkelsen et al.
2007). Considering these features associated with the
chromatin at Sox2 enhancers and flanking region, it is also
possible that Sox2ot plays a role in regulating chromatin
structure, a rapidly emerging theme for regulatory RNAs
(Rinn et al. 2007; Ebisuya et al. 2008; Pandey et al. 2008; Yu
et al. 2008; for review, see Mattick et al. 2009). Indeed,
recent evidence indicate that a large proportion of lincRNAs,
which are also conserved long, spliced ncRNAs, directly
associate with different chromatin modifying complexes
and can affect the expression of genes that are targeted by
these complexes (Khalil et al. 2009). Finally, a regulatory
role for Sox2ot may depend on the act of transcrip-
tion itself, as observed for specific ncRNA loci involved in
chromatin and transcriptional remodeling in yeast and
mammalian cells (Ebisuya et al. 2008; Hirota et al. 2008).
However, the stability, regulated splicing patterns, pre-
dicted secondary structure, and conservation of Sox2ot
transcripts (Fig. 1) suggest that the transcript has intrinsic
functions.
Gain- and loss-of-function strategies to determine Sox2ot
mechanism of action and relationship with Sox2 are
warranted, for example, using morpholinos to block sox2ot
splicing in zebrafish embryos and siRNA knockdown
in ES cells, an approach that has proved successful in
identifying functional roles for an increasing number of
ncRNAs (Mattick 2009). The elucidation of these roles
may help to understand the different developmental pro-
cesses, and potentially the related disorders, in which
Sox2ot is expressed. Linkage disequilibrium analysis has
already implicated the upstream regions of SOX2OT as
a myopia common susceptibility locus, and the ncRNA
was suggested to be a plausible candidate (Andrew et al.
2008), with perturbations in its expression patterns possibly
involved, as has also been proposed for ncRNAs present in
other disease susceptibility loci (Shirasawa et al. 2004; He
et al. 2009).
In conclusion, this study provides insight into the range
of structural isoforms, epigenetic modifications, and ex-
pression patterns of the Sox2ot gene and its transcripts. It
also highlights the hidden complexity of such loci and of
the biological processes in which they are likely to partic-
ipate, consistent with the emerging view of the eukaryotic
genome as an RNA machine (Amaral et al. 2008). Indeed,
another ncRNA located z100 kb downstream from Sox2
was recently shown to be expressed specifically in mouse ES
cells and to be a direct target of Sox2 and Oct4, as part of
a collection of over a thousand novel spliced ncRNAs
identified (Guttman et al. 2009). Similar to the Sox2ot
locus, identification and characterization of unnanotated
transcripts with orthologs in amenable model organisms
may represent a general approach to explore the roles of
ncRNAs in developmental processes.
Amaral et al.
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MATERIALS AND METHODS
Mouse tissue samples and cell culture
Mouse W9.5 ES cells at low passage number were maintained in
15% fetal calf serum (FCS) on mitotically inactive MEFs with 1000
U/mL LIF, as previously described (Bruce et al. 2007; Dinger et al.
2008a). Embryoid bodies were differentiated in Dulbecco’s mod-
ified Eagle’s medium (DMEM) containing 10% FCS in 1%
methylcellulose (GIBCO 10912-012), which efficiently induces
mesoderm-differentiation programs (Bruce et al. 2007; Dinger
et al. 2008a). For RNA Polymerase II inhibition experiments, ES
cells were seeded at 1 3 105 cells/mL in 6 cm plates in 10% FCS
DMEM with or without 20 mg/mL a-amanitin (Sigma A2263)
(and with or without LIF) and harvested after 0, 12, 24, and 48 h
of culture. Whole neurospheres were generated from adult neural
stem cells and proliferating precursor cells harvested from the
subventricular zone of 12 mo old mice, passaged and differenti-
ated as described by Rietze and Reynolds (2006), and were kindly
provided by Beatrice Large and Rod Rietze. Mouse mammary
epithelial HC11 cells (Ball et al. 1988) were cultured in RPMI 1640
medium supplemented with 10% FCS, 5 mg/mL insulin, and
10 ng/mL EGF. Mouse testis-derived cell lines TM3 (ATCC no.
CRL-1714) and TM4 (ATCC no. CRL-1715) were cultured in
high-glucose DMEM medium containing 10% FCS, 2.5 mM
L-glutamine and 0.5 mM sodium pyruvate.
Mouse tissues dissected from adult CD1 or C57BL mice, and
embryos dissected from pregnant C57BL mice at 10, 11, and 12
dpc (E10–E12) were frozen in liquid nitrogen and stored at 80°C
until later used for RNA extraction.
RNA isolation and RT-PCR expression analysis
RNA from zebrafish embryos, mouse tissues, and cell cultures was
purified using Trizol (Invitrogen) or RNeasy Mini Kit (Qiagen)
and treated with DNase I (Invitrogen), according to instructions
of the manufacturers. RNA samples from chicken embryos were
kindly provided by Evgeny Glazov, and total RNA from human
tissues was purchased from Ambion (AM6000). cDNA prepara-
tion and quantitative real-time PCR (qRT-PCR) analysis were
performed as described (Bruce et al. 2007). Primers were designed
based on Sox2ot EST sequences available for different vertebrates,
spanning splice sites in most cases (Supplemental Table 2), and
PCR products were sequenced to confirm the identity of the
fragments. For normalization of transcript expression levels, Hprt
and eF1a were used as internal controls in mouse and zebrafish
samples, respectively. For qRT-PCR analysis of a-amanitin in-
hibition experiments, as well as for human and chicken expression
analysis, cDNA was produced using random primers and expres-
sion values normalized relative to 18S RNA expression. For mouse
tissue expression analysis, cDNA was used in PCR for 35 cycles
and amplification products were visualized after electrophoresis
in 2%–3% agarose gels. For in situ hybridization (ISH) probe
preparation, cDNA from ES cells, and mouse or zebrafish embryos
was amplified (see primers in Supplemental Table 2) and PCR
products were cloned into pGEM-T Easy Vectors (Promega)
(sequenced to confirm the identity of the insert), which were
then used in PCR with T7 and SP6 primers to generate DNA
templates for in vitro transcription reactions. ISH probe sequences
are listed in Supplemental Table 2.
Northern blot analysis
For Northern blot analysis, 10 mg of total RNA were electro-
phoresed at 90 V for 3 h and 20 min through 1.2% agarose gels
containing 1.1% formaldehyde in buffer 1X MOPS, 0.2 M sodium
acetate (pH 7.0), and 0.01 M Na2EDTA (1 M stock solution to pH
8.0). After electrophoresis, RNA gels were rinsed twice in distilled
water and then washed in 10X SSC (3 M NaCl, 0.3 M sodium
citrate at pH 7.0) at room temperature for 45 min. RNA was
transferred overnight to Hybond-N+ membranes (Amersham
Biosciences) by capillary blotting and fixed to the membranes
by baking at 80°C for 2 h. The blots were probed with 32P-labeled
probes (Supplemental Table 2), which were prepared by PCR and
purified amplification products labeled using Megaprime DNA
Labeling Systems (Amersham Biosciences), following the manu-
facturer’s instructions. Band size was estimated using 0.5–10 kb
RNA Ladder (Invitrogen).
Zebrafish material and in situ hybridization
AB strain zebrafish stocks were reared and embryos obtained as
described (Westerfield 1994). Embryos were incubated at 28.5°C
and staged as previously described (Kimmel et al. 1995). All
experiments were performed subject to animal ethics committee
approval (AEC no. IMB/167/06/ARC).
For whole-mount in situ hybridization with zebrafish embryos,
riboprobe templates were generated by PCR using primers
that included T7/SP6 promoter sequences as described above.
Riboprobe synthesis and in situ hybridizations were performed
as previously described (Wilkins et al. 2008), and section ISH
performed with 7 mm sections, as described by Wilhelm et al.
(2007).
Electronic expression and secondary structure
analysis
Available microarray expression data for SOX2OT in several
normal human tissues were obtained from the Gene Expression
Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/),
deposited under GEO Data set Record GDS423, which contains
expression data for 12 normal human tissues interrogated with
Affymetrix GeneChip HG-U95B (ProbeSet 55950) (Yanai et al.
2005), and Data set Record GDS1085, which analyzed the
expression profile of 35 different types of normal tissues (ProbeSet
34804) (Shyamsundar et al. 2005).
For electronic expression analysis, SOX2OT spliced ESTs in
human tissue libraries present in GenBank were catalogued, and
the number of SOX2OT EST clones was computed for each tissue
library (Supplemental Table 1). SOX2OT EST frequency ( f ) in
each tissue was calculated by dividing the number of SOX2OT
EST clones (x) by the total number of clones per tissue (n).
Finally, the ‘‘relative SOX2OT expression’’ in human tissues was
obtained by normalizing the frequency in each library ( f ) by the
total number of SOX2OT ESTs in all libraries (expressed as
a percentile) (Fig. 4F; Supplemental Table 1).
In the secondary structure analysis, a 106 nt region associated to
the conserved sequence of Sox2otwas identified by RNAz (Washietl
et al. 2005) with P > 0.9, as described by Dinger et al. (2008a).
Additional secondary structure analysis was performed using
the most recent RNAalifold algorithm with RIBOSUM scoring
Sox2ot transcripts in vertebrate development
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(http://rna.tbi.univie.ac.at/cgi-bin/RNAalifold.cgi). RNAalifold pre-
dicts the consensus structure from a set of aligned sequences taking
into account both thermodynamic stability and sequence covaria-
tion (Bernhart et al. 2008). The 17-Way species multiple genome
alignment from the UCSC genome browser was used as input.
SUPPLEMENTAL MATERIAL
Supplemental material can be found at http://www.rnajournal.org.
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